These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18545772)

  • 21. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
    Vacherot F; Attarian S; Eusebio A; Azulay JP
    Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and cognitive profiles of patients with both Parkinson's disease and essential tremor.
    Ozen Barut B; Gunal DI; Turkmen C; Mollahasanoğlu A; Ankaralı H
    Acta Neurol Belg; 2013 Jun; 113(2):117-25. PubMed ID: 22926528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of levodopa on the habituation of the acoustic-palpebral reflex in Parkinson's disease.
    Rey RD; Garretto NS; Bueri JA; Simonetti DD; Sanz OP; Sica RE
    Electromyogr Clin Neurophysiol; 1996 Sep; 36(6):357-60. PubMed ID: 8891475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of Parkinson's disease and levodopa on adaptation of anticipatory postural adjustments.
    Hall LM; Brauer SG; Horak F; Hodges PW
    Neuroscience; 2013 Oct; 250():483-92. PubMed ID: 23867768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
    Parkinson Study Group
    JAMA; 2002 Apr; 287(13):1653-61. PubMed ID: 11926889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
    Okada Y; Murata M; Toda T
    Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Working memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.
    Fournet N; Moreaud O; Roulin JL; Naegele B; Pellat J
    Neuropsychology; 2000 Apr; 14(2):247-53. PubMed ID: 10791864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Parkinson's disease. Advances in the pharmacological therapy.
    Ghika J
    Eur Neurol; 1996; 36(6):396-9. PubMed ID: 8954312
    [No Abstract]   [Full Text] [Related]  

  • 32. Levodopa improves time-based prospective memory in Parkinson's disease.
    Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
    J Int Neuropsychol Soc; 2008 Jul; 14(4):601-10. PubMed ID: 18577289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease.
    Varanese S; Howard J; Di Rocco A
    Mov Disord; 2010 Mar; 25(4):508-10. PubMed ID: 20014061
    [No Abstract]   [Full Text] [Related]  

  • 36. Spatial structure normalises working memory performance in Parkinson's disease.
    Fallon SJ; Bor D; Hampshire A; Barker RA; Owen AM
    Cortex; 2017 Nov; 96():73-82. PubMed ID: 28985531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys.
    Fernández-Ruiz J; Doudet D; Aigner TG
    Psychopharmacology (Berl); 1999 Nov; 147(1):104-7. PubMed ID: 10591875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD).
    Morrison CE; Borod JC; Brin MF; Hälbig TD; Olanow CW
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1333-41. PubMed ID: 15480842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Levodopa and cognitive disorders in Parkinson's disease].
    Leiva-Santana C; Alvarez-Saúco M
    Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.